We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$257M
AUM Growth
+$20.3M
Cap. Flow
-$3.38M
Cap. Flow %
-1.32%
Top 10 Hldgs %
33.42%
Holding
167
New
24
Increased
41
Reduced
51
Closed
33

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.37M
2
ULTA icon
Ulta Beauty
ULTA
+$2.18M
3
COP icon
ConocoPhillips
COP
+$2.04M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.97M
5
EMR icon
Emerson Electric
EMR
+$1.81M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$4.77M
2
UBER icon
Uber
UBER
+$3.19M
3
PANW icon
Palo Alto Networks
PANW
+$2.27M
4
CRWD icon
CrowdStrike
CRWD
+$2.23M
5
DHI icon
D.R. Horton
DHI
+$2.13M

Sector Composition

Rank Sector Weight
1 Industrials 24.01%
2 Healthcare 17.6%
3 Financials 14.71%
4 Technology 12.6%
5 Communication Services 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
51
ExxonMobil
XOM
$644B
$1.69M 0.66%
12,389
-3,920
-24% -$587K
CP icon
52
Canadian Pacific Kansas City
CP
$78.1B
$1.62M 0.63%
18,698
+2,318
+14% +$199K
PPG icon
53
PPG Industries
PPG
$24.6B
$1.56M 0.61%
12,880
+4,900
+61% +$546K
CFG icon
54
Citizens Financial Group
CFG
$30.3B
$1.56M 0.61%
22,232
-285
-1% -$18.4K
IR icon
55
Ingersoll Rand
IR
$32.6B
$1.56M 0.61%
18,984
-1,275
-6% -$98.6K
AIR icon
56
AAR Corp
AIR
$5.59B
$1.53M 0.6%
10,700
-2,675
-20% -$316K
SCHW
57
Charles Schwab
SCHW
$183B
$1.51M 0.59%
+16,325
New +$1.49M
RY icon
58
Royal Bank of Canada
RY
$291B
$1.47M 0.57%
7,100
-1,600
-18% -$297K
CRH icon
59
CRH
CRH
$63.2B
$1.47M 0.57%
13,717
-875
-6% -$96.3K
WM icon
60
Waste Management
WM
$90.6B
$1.47M 0.57%
6,582
+575
+10% +$128K
NEM icon
61
Newmont
NEM
$98.7B
$1.47M 0.57%
+15,700
New +$1.71M
ZTS icon
62
Zoetis
ZTS
$32.4B
$1.33M 0.52%
18,461
-1,930
-9% -$182K
MAS icon
63
Masco
MAS
$14.1B
$1.31M 0.51%
16,050
-600
-4% -$41.9K
TMO icon
64
Thermo Fisher Scientific
TMO
$213B
$1.3M 0.51%
2,588
+1,175
+83% +$564K
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$121B
$1.28M 0.5%
2,575
+975
+61% +$432K
PH icon
66
Parker-Hannifin
PH
$123B
$1.27M 0.49%
1,295
+495
+62% +$453K
TECK icon
67
Teck Resources
TECK
$29.6B
$1.23M 0.48%
+20,700
New +$1.26M
PNR icon
68
Pentair
PNR
$10.4B
$1.17M 0.45%
+15,225
New +$1.2M
WFC icon
69
Wells Fargo
WFC
$261B
$1.15M 0.45%
13,927
-19,223
-58% -$1.54M
LNG icon
70
Cheniere Energy
LNG
$55.2B
$1.12M 0.44%
+4,700
New +$1.17M
WASH icon
71
Washington Trust Bancorp
WASH
$743M
$1.08M 0.42%
29,700
– –
INDB icon
72
Independent Bank
INDB
$3.99B
$1.07M 0.41%
12,730
-262
-2% -$20.8K
UPS icon
73
United Parcel Service
UPS
$88.6B
$1.06M 0.41%
9,890
-325
-3% -$33.8K
TDG icon
74
TransDigm Group
TDG
$70.2B
$977K 0.38%
734
-17
-2% -$20.9K
INVH icon
75
Invitation Homes
INVH
$17.7B
$930K 0.36%
30,788
-4,525
-13% -$128K
1 2
3
4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2026 Portfolio in Review

As of Q2 2026, New England Research & Management held 167 positions worth $257M, up 8.6% from $237M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

New England Research & Management's Q2 2026 filing shows 24 new, 41 increased, 51 reduced and 33 closed positions. Its largest new stake was Ulta Beauty: 4,303 shares worth $1.94M. The largest sale was Capital One, an estimated $4.77M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • New England Research & Management's largest Q2 2026 buy was Ulta Beauty: 4,303 shares worth $1.94M.
  • New England Research & Management added most to AstraZeneca in Q2 2026, an estimated $2.37M increase.
  • New England Research & Management's biggest Q2 2026 reduction was Idexx Laboratories, cutting an estimated $1.82M.
  • New England Research & Management fully exited Capital One in Q2 2026, selling an estimated $4.77M.
  • New England Research & Management's ten largest holdings make up 33% of its $257M portfolio in Q2 2026.
  • New England Research & Management opened 24 new positions and closed 33 in Q2 2026.
  • New England Research & Management's portfolio value rose 8.6% quarter-over-quarter to $257M.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.